Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,250 | -5,361 | -3,162 | -8,801 | -8,918 |
| Depreciation Amortization | 37 | 24 | 13 | 50 | 36 |
| Accounts payable and accrued liabilities | -603 | -239 | -291 | 128 | -178 |
| Other Working Capital | -739 | -483 | -65 | -123 | 340 |
| Other Operating Activity | 728 | 743 | 891 | -43 | 2,666 |
| Operating Cash Flow | $-7,828 | $-5,316 | $-2,614 | $-8,787 | $-6,055 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -3 | -3 | -44 | -38 |
| Investing Cash Flow | $-29 | $-3 | $-3 | $-44 | $-38 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,289 | N/A | 5,231 | 4,906 |
| Common Stock Repurchased | 3,726 | 1,045 | N/A | N/A | 142 |
| Other Financing Activity | 0 | 0 | 0 | 5,031 | 4,262 |
| Financing Cash Flow | $3,726 | $3,334 | $N/A | $10,261 | $9,309 |
| Beginning Cash Position | 27,646 | 27,646 | 27,646 | 26,217 | 26,217 |
| End Cash Position | 23,516 | 25,661 | 25,029 | 27,646 | 29,434 |
| Net Cash Flow | $-4,130 | $-1,985 | $-2,617 | $1,430 | $3,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,828 | -5,316 | -2,614 | -8,787 | -6,055 |
| Capital Expenditure | -29 | -4 | -4 | -44 | -38 |
| Free Cash Flow | -7,857 | -5,320 | -2,617 | -8,832 | -6,093 |